Bavencio

Medicinal product

(Invented) name

Bavencio

Active substance (s)

Avelumabas

Strength

20 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FF04, Avelumab

Marketing authorisation holder

Merck Europe B.V., Nyderlandai

Date of authorisation

2017-09-18

Date of renewal

Documents

Bavencio paciento kortele.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for solution for infusion	1 ml
Avelumabas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
97849	83944	1083944	flakonas	10 ml N1		Receptinis	EU/1/17/1214/001	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-09-18	Registruotas